Abstract
There are several classification problems, which are difficult to solve using a single classifier because of the complexity of the decision boundary. Whereas a wide variety of multiple classifier systems have been built with the purpose of improving the recognition process, there is no universal method performing the best. This paper provides a review of different multi-classifiers and some application of them. Also it is shown a novel model of combining classifiers and its application to predicting human immunodeficiency virus drug resistance from genotype. The proposal is based on the use of different classifier models. It clusters the dataset considering the performance of the base classifiers. The system learns how to decide from the groups, by using a meta-classifier, which are the best classifiers for a given pattern. The proposed model is compared with well-known classifier ensembles and individual classifiers as well resulting the novel model in similar or even better performance.
Keywords: Classification, Ensemble classifiers, HIV prediction, Machine learning, Multi-classifiers.
Current Topics in Medicinal Chemistry
Title:Multi-Classifier Based on Hard Instances- New Method for Prediction of Human Immunodeficiency Virus Drug Resistance
Volume: 13 Issue: 5
Author(s): Isis Bonet, Joel Arencibia, Mario Pupo, Abdel Rodriguez, Maria M. Garcia and Ricardo Grau
Affiliation:
Keywords: Classification, Ensemble classifiers, HIV prediction, Machine learning, Multi-classifiers.
Abstract: There are several classification problems, which are difficult to solve using a single classifier because of the complexity of the decision boundary. Whereas a wide variety of multiple classifier systems have been built with the purpose of improving the recognition process, there is no universal method performing the best. This paper provides a review of different multi-classifiers and some application of them. Also it is shown a novel model of combining classifiers and its application to predicting human immunodeficiency virus drug resistance from genotype. The proposal is based on the use of different classifier models. It clusters the dataset considering the performance of the base classifiers. The system learns how to decide from the groups, by using a meta-classifier, which are the best classifiers for a given pattern. The proposed model is compared with well-known classifier ensembles and individual classifiers as well resulting the novel model in similar or even better performance.
Export Options
About this article
Cite this article as:
Bonet Isis, Arencibia Joel, Pupo Mario, Rodriguez Abdel, Garcia Maria M. and Grau Ricardo, Multi-Classifier Based on Hard Instances- New Method for Prediction of Human Immunodeficiency Virus Drug Resistance, Current Topics in Medicinal Chemistry 2013; 13 (5) . https://dx.doi.org/10.2174/1568026611313050011
DOI https://dx.doi.org/10.2174/1568026611313050011 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index To Volume 12
Current Pharmaceutical Design Tocotrienols Target PI3K/Akt Signaling in Anti-Breast Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Inhibitors of the Chemokine Receptor CXCR4: Chemotherapy of AIDS, Metastatic Cancer, Leukemia and Rheumatoid Arthritis
Letters in Drug Design & Discovery Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era
Current Molecular Pharmacology Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions
Current Angiogenesis (Discontinued) Sam Domains in Multiple Diseases
Current Medicinal Chemistry Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) PET and SPECT Radiotracers to Assess Function and Expression of ABC Transporters In Vivo
Current Drug Metabolism Identification of Tumor Targeting Agents by Phage Display
Medicinal Chemistry Reviews - Online (Discontinued) Properties and Pathogenicity of Prion-Derived Peptides
Protein & Peptide Letters Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Recent Patents on CNS Drug Discovery (Discontinued) The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells
Current Cancer Drug Targets The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets Patient-Specific Alpha-Particle Dosimetry
Current Radiopharmaceuticals C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors
Current Cancer Drug Targets Chromosomal Aberrations and Genomic Instability Induced by Topoisomerase- Targeted Antitumour Drugs
Current Medicinal Chemistry - Anti-Cancer Agents LRRC4 Inhibits Glioma Cell Growth and Invasion Through a miR-185- Dependent Pathway
Current Cancer Drug Targets Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry Sulfation of Phenylephrine by the Human Cytosolic Sulfotransferases
Drug Metabolism Letters